Olivier Chosidow
Olivier Chosidow is an expert in Dermatology at Hôpitaux Universitaires Henri-Mondor (France). As of October 2026, ScienceLeadR ranks Olivier Chosidow in the top 1% of experts worldwide for Erythema, Syphilis and Sexually Transmitted Diseases. Olivier Chosidow has authored 944 publications, the most recent in 2026, and is an investigator in 28 clinical trials, 5 of them ongoing. SLR score: 2,854 (community average: 125). How the SLR is computed.
LeadR Profile
Dermatology
Subspecialties: Infectiology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1989 - 2026
Number : 944
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Dermatophilus congolensis: An emerging urban sexually transmitted infectious disease. PMID 42786927 — dermatophilus, sexually transmitted diseases, doxycycline, folliculitis, communicable diseases | J Eur Acad Dermatol Venereol | 2026 | 0 |
| Oral Ivermectin and 5% Permethrin Cream for Severe Scabies. Reply. PMID 42617127 — ivermectin, permethrin, scabies | N Engl J Med Top journal | 2026 | 0 |
| The spectrum of eosinophilic cellulitis (Wells' syndrome): new insights based on 114 cases. PMID 42551694 — hypersensitivity, adrenal cortex hormones, cellulitis, eosinophils, therapeutics | J Allergy Clin Immunol Pract | 2026 | 0 |
| Evaluation of Clinicians' Knowledge of Terbinafine-resistant Extensive Dermatophytosis in France. PMID 42478828 — sexually transmitted diseases, terbinafine, dermatology, tinea | Acta Derm Venereol | 2026 | 0 |
| Recurrent Facial Folliculitis Caused by Klebsiella aerogenes Sequence Type 117 in Men who Have Sex with Men. PMID 42366116 — sexually transmitted diseases, communicable disease control, enterobacter aerogenes, sex, klebsiella, folliculitis, bacteria | Emerg Infect Dis | 2026 | 0 |
Clinical Studies 28
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 1
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Biologics in Folliculitis Decalvans an Adaptative Trial Research NCT07268534 — ustekinumab, interleukin-12, folliculitis, research, adalimumab, therapeutics, alopecia | Phase 2 | Not yet recruiting | 2026 |
| Comparing Short to Standard Amoxicillin Course for Erysipelas NCT07104552 — general practitioners, amoxicillin, erysipelas, therapeutics, dermatology, infections | Phase 4 | Not yet recruiting | 2026 |
| Severe Erythema Multiforme CORTICO NCT06266221 — prednisolone, methylprednisolone acetate, eating, methylprednisolone, prednisone, adrenal cortex hormones, acetates, food, erythema multiforme, wounds and injuries, methylprednisolone hemisuccinate, erythema | Phase 3 | Not yet recruiting | 2024 |
| Role of Gut Microbiota in the Pathophysiology of Aseptic Abscesses NCT05537909 — abscess, blood, specimen handling, therapeutics, gastrointestinal microbiome, microbiota | N/A | Recruiting | 2021 |
| Nonavalent HPV Vaccine in the Treatment of Difficult to treat Palmo plantar Warts NCT04814446 — injections, vaccines, foot, vaccination, warts, therapeutics, injections, intramuscular, foot diseases | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map